| Product Code: ETC7549468 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Oncology Based Molecular Diagnostics Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Oncology Based Molecular Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 India Oncology Based Molecular Diagnostics Market - Industry Life Cycle |
3.4 India Oncology Based Molecular Diagnostics Market - Porter's Five Forces |
3.5 India Oncology Based Molecular Diagnostics Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 India Oncology Based Molecular Diagnostics Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 India Oncology Based Molecular Diagnostics Market Revenues & Volume Share, By Product, 2021 & 2031F |
4 India Oncology Based Molecular Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence of cancer cases in India |
4.2.2 Advancements in molecular diagnostics technologies |
4.2.3 Growing awareness about early cancer detection and personalized treatment options |
4.3 Market Restraints |
4.3.1 High cost associated with molecular diagnostics tests |
4.3.2 Limited access to advanced diagnostic technologies in rural areas |
4.3.3 Regulatory challenges and approvals for new diagnostic tests |
5 India Oncology Based Molecular Diagnostics Market Trends |
6 India Oncology Based Molecular Diagnostics Market, By Types |
6.1 India Oncology Based Molecular Diagnostics Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 India Oncology Based Molecular Diagnostics Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 India Oncology Based Molecular Diagnostics Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.1.4 India Oncology Based Molecular Diagnostics Market Revenues & Volume, By Prostate Cancer, 2021- 2031F |
6.1.5 India Oncology Based Molecular Diagnostics Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F |
6.1.6 India Oncology Based Molecular Diagnostics Market Revenues & Volume, By Cervical Cancer, 2021- 2031F |
6.1.7 India Oncology Based Molecular Diagnostics Market Revenues & Volume, By Liver Cancer, 2021- 2031F |
6.1.8 India Oncology Based Molecular Diagnostics Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.1.9 India Oncology Based Molecular Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 India Oncology Based Molecular Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
6.2 India Oncology Based Molecular Diagnostics Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 India Oncology Based Molecular Diagnostics Market Revenues & Volume, By PCR, 2021- 2031F |
6.2.3 India Oncology Based Molecular Diagnostics Market Revenues & Volume, By In situ hybridization, 2021- 2031F |
6.2.4 India Oncology Based Molecular Diagnostics Market Revenues & Volume, By INAAT, 2021- 2031F |
6.2.5 India Oncology Based Molecular Diagnostics Market Revenues & Volume, By Chips and microarrays, 2021- 2031F |
6.2.6 India Oncology Based Molecular Diagnostics Market Revenues & Volume, By Mass spectrometry, 2021- 2031F |
6.2.7 India Oncology Based Molecular Diagnostics Market Revenues & Volume, By Sequencing, 2021- 2031F |
6.2.8 India Oncology Based Molecular Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
6.2.9 India Oncology Based Molecular Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
6.3 India Oncology Based Molecular Diagnostics Market, By Product |
6.3.1 Overview and Analysis |
6.3.2 India Oncology Based Molecular Diagnostics Market Revenues & Volume, By Instruments, 2021- 2031F |
6.3.3 India Oncology Based Molecular Diagnostics Market Revenues & Volume, By Reagents, 2021- 2031F |
6.3.4 India Oncology Based Molecular Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
7 India Oncology Based Molecular Diagnostics Market Import-Export Trade Statistics |
7.1 India Oncology Based Molecular Diagnostics Market Export to Major Countries |
7.2 India Oncology Based Molecular Diagnostics Market Imports from Major Countries |
8 India Oncology Based Molecular Diagnostics Market Key Performance Indicators |
8.1 Number of cancer cases diagnosed using molecular diagnostics |
8.2 Adoption rate of molecular diagnostic tests in oncology clinics and hospitals |
8.3 Research and development investment in new molecular diagnostic technologies |
8.4 Number of partnerships and collaborations for expanding access to molecular diagnostics |
8.5 Patient outcomes and survival rates post molecular diagnostics testing |
9 India Oncology Based Molecular Diagnostics Market - Opportunity Assessment |
9.1 India Oncology Based Molecular Diagnostics Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 India Oncology Based Molecular Diagnostics Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 India Oncology Based Molecular Diagnostics Market Opportunity Assessment, By Product, 2021 & 2031F |
10 India Oncology Based Molecular Diagnostics Market - Competitive Landscape |
10.1 India Oncology Based Molecular Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 India Oncology Based Molecular Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here